Lara Sullivan
Chief Executive Officer · Pyxis Oncology, Inc.
Individual
- 2024
- Dec 23, 2024
- 1
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Lara Sullivan files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Jakob Dupont - $107K in PYXS purchases and sales in the last 12 months
- GordonMD Global Investments LP - PYXS
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Lara Sullivan?
Lara Sullivan is a corporate insider, tracked as Chief Executive Officer of Pyxis Oncology, Inc. (PYXS). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Lara Sullivan last file a Form 4?
The only primary Form 4 on record is dated 23 December 2024.